Cellcept and Pathogen resistance - a phase IV clinical study of FDA data

Summary:

Pathogen resistance is reported as a side effect among people who take Cellcept (mycophenolate mofetil), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Prograf, and have High blood pressure.

The phase IV clinical study analyzes which people have Pathogen resistance when taking Cellcept. It is created by eHealthMe based on reports of 41,092 people who have side effects when taking Cellcept from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Pathogen resistance?

Pathogen resistance is found to be associated with 445 drugs and 596 conditions by eHealthMe. Check the latest studies of Pathogen resistance.

On Jun, 17, 2026

41,092 people reported to have side effects when taking Cellcept.
Among them, 42 people (0.1%) have Pathogen resistance.

Could Cellcept cause Pathogen resistance?

Among these 42 people:

How long have people been on Cellcept when they have Pathogen resistance? *

What is the gender of people who have Pathogen resistance when taking Cellcept? *

female: 38.1 %
male: 61.9 %

What is the age of people who have Pathogen resistance when taking Cellcept? *

What are other drugs people take besides Cellcept? *

What are other side effects people have besides Pathogen resistance? *

Cytomegalovirus Infection: 5 people, 11.90%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 5 people, 11.90%
Fever: 5 people, 11.90%
Drug Hypersensitivity: 5 people, 11.90%
Klebsiella Infection: 4 people, 9.52%
Diarrhea: 4 people, 9.52%
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 4 people, 9.52%
Thrombocytopenia (decrease of platelets in blood): 4 people, 9.52%
Renal Impairment (severely reduced kidney function): 4 people, 9.52%
Multi-Organ Failure (multisystem organ failure): 4 people, 9.52%

What are the existing conditions these people have? *

Immunodeficiency Disorders: 4 people, 9.52%
High Blood Pressure: 4 people, 9.52%
Hidradenitis (chronic disease of a type of sweat gland): 3 people, 7.14%
Pleural Infection Bacterial (bacterial lung infection): 3 people, 7.14%
Peritoneal Infection: 3 people, 7.14%
Escherichia Sepsis (bacterial infection by escherichia coli): 3 people, 7.14%
Pain: 2 people, 4.76%
Cytomegalovirus Infection: 2 people, 4.76%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 4.76%
Staphylococcal Infection (an infection with staphylococcus bacteria): 2 people, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and have Pathogen resistance?

- Check whether Pathogen resistance is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cellcept:

Cellcept (41,872 reports)

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pathogen resistance:

Pathogen resistance (445 drugs)

Browse all the conditions that are associated with Pathogen resistance:

Pathogen resistance (596 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.